Why the study?
Does ticlopidine improve clinical outcomes compared to aspirin in patients requiring antiplatelet therapy?
Population
Patients requiring antiplatelet therapy, including those at risk for stroke, with unstable angina, or…
Comparison
Ticlopidine vs Aspirin and other antiplatelet agents
Design
Review
Authors
Loading...
May warrant consideration in aspirin-intolerant patients; leaves open need for updated RCTs versus contemporary agents.
Does ticlopidine improve clinical outcomes compared to aspirin in patients requiring antiplatelet therapy?
Ticlopidine is an effective alternative to aspirin for stroke prevention, particularly in patients who cannot tolerate or do not benefit from aspirin, though its use is limited by neutropenia risk.
Flores-Runk et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: